These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30571186)

  • 21. Higher plasma GlycA, a novel pro-inflammatory glycoprotein biomarker, is associated with reduced life expectancy: The PREVEND study.
    Gruppen EG; Connelly MA; Sluiter WJ; Bakker SJL; Dullaart RPF
    Clin Chim Acta; 2019 Jan; 488():7-12. PubMed ID: 30365925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher circulating GlycA, a pro-inflammatory glycoprotein biomarker, relates to lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in diabetic or metabolic syndrome subjects.
    Gruppen EG; Connelly MA; Dullaart RP
    J Clin Lipidol; 2016; 10(3):512-8. PubMed ID: 27206938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls.
    Bartlett DB; Connelly MA; AbouAssi H; Bateman LA; Tune KN; Huebner JL; Kraus VB; Winegar DA; Otvos JD; Kraus WE; Huffman KM
    Arthritis Res Ther; 2016 Apr; 18():86. PubMed ID: 27067270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk.
    Connelly MA; Otvos JD; Shalaurova I; Playford MP; Mehta NN
    J Transl Med; 2017 Oct; 15(1):219. PubMed ID: 29078787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease.
    Prokić I; Lahousse L; de Vries M; Liu J; Kalaoja M; Vonk JM; van der Plaat DA; van Diemen CC; van der Spek A; Zhernakova A; Fu J; Ghanbari M; Ala-Korpela M; Kettunen J; Havulinna AS; Perola M; Salomaa V; Lind L; Ärnlöv J; Stricker BHC; Brusselle GG; Boezen HM; van Duijn CM; Amin N
    BMC Pulm Med; 2020 Jul; 20(1):193. PubMed ID: 32677943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum alpha-1 antitrypsin is a major component of GlycA-associated risk for future morbidity and mortality.
    Ritchie SC; Kettunen J; Brozynska M; Nath AP; Havulinna AS; Männistö S; Perola M; Salomaa V; Ala-Korpela M; Abraham G; Würtz P; Inouye M
    PLoS One; 2019; 14(10):e0223692. PubMed ID: 31644575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palestinian Arab ethnicity is associated with an adverse metabolic phenotype.
    Weiss R; Nassar H; Sinnreich R; Abu-Ahmad W; Otvos J; Kark JD
    Clin Chim Acta; 2017 Dec; 475():56-63. PubMed ID: 28987777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus.
    Akinkuolie AO; Pradhan AD; Buring JE; Ridker PM; Mora S
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1544-50. PubMed ID: 25908766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GlycA, a marker of protein glycosylation, is related to albuminuria and estimated glomerular filtration rate: the ELSA-Brasil study.
    Titan SM; Pecoits-Filho R; Barreto SM; Lopes AA; Bensenor IJ; Lotufo PA
    BMC Nephrol; 2017 Dec; 18(1):367. PubMed ID: 29262791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Jang S; Ogunmoroti O; Zhao D; Fashanu OE; Tibuakuu M; Benson EM; Norby F; Otvos JD; Heckbert SR; Szklo M; Michos ED
    PLoS One; 2021; 16(3):e0248644. PubMed ID: 33765041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis.
    Ormseth MJ; Chung CP; Oeser AM; Connelly MA; Sokka T; Raggi P; Solus JF; Otvos JD; Stein CM
    Arthritis Res Ther; 2015 May; 17(1):117. PubMed ID: 25956924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection.
    Ritchie SC; Würtz P; Nath AP; Abraham G; Havulinna AS; Fearnley LG; Sarin AP; Kangas AJ; Soininen P; Aalto K; Seppälä I; Raitoharju E; Salmi M; Maksimow M; Männistö S; Kähönen M; Juonala M; Ripatti S; Lehtimäki T; Jalkanen S; Perola M; Raitakari O; Salomaa V; Ala-Korpela M; Kettunen J; Inouye M
    Cell Syst; 2015 Oct; 1(4):293-301. PubMed ID: 27136058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GlycA, a biomarker of inflammatory glycoproteins, is more closely related to the leptin/adiponectin ratio than to glucose tolerance status.
    Dullaart RP; Gruppen EG; Connelly MA; Otvos JD; Lefrandt JD
    Clin Biochem; 2015 Aug; 48(12):811-4. PubMed ID: 25977069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GlycA, a novel inflammatory marker, is associated with subclinical coronary disease.
    Tibuakuu M; Fashanu OE; Zhao D; Otvos JD; Brown TT; Haberlen SA; Guallar E; Budoff MJ; Palella FJ; Martinson JJ; Akinkuolie AO; Mora S; Post WS; Michos ED
    AIDS; 2019 Mar; 33(3):547-557. PubMed ID: 30475263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Associations of Inflammatory Markers With Insulin Sensitivity and Secretion: The Prospective METSIM Study.
    Fizelova M; Jauhiainen R; Kangas AJ; Soininen P; Ala-Korpela M; Kuusisto J; Laakso M; Stancáková A
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3600-3609. PubMed ID: 28911155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of GlycA and high-sensitivity C-reactive protein with measures of lipolysis in adults with obesity.
    Levine JA; Han JM; Wolska A; Wilson SR; Patel TP; Remaley AT; Periwal V; Yanovski JA; Demidowich AP
    J Clin Lipidol; 2020; 14(5):667-674. PubMed ID: 32863171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma levels of GlycA, a pro-inflammatory glycoprotein biomarker, associate with an increased risk of microvascular complications in patients with type 2 diabetes (Zodiac-62).
    Bourgonje AR; van der Vaart A; Gruppen EG; van Goor H; Bakker SJL; Connelly MA; van Dijk PR; Dullaart RPF
    Endocrine; 2023 May; 80(2):312-316. PubMed ID: 36757630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pro-inflammatory glycoprotein biomarker is associated with lower bilirubin in metabolic syndrome.
    Dullaart RP; Gruppen EG; Connelly MA; Lefrandt JD
    Clin Biochem; 2015 Nov; 48(16-17):1045-7. PubMed ID: 26129880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association Between Smoking and Serum GlycA and High-Sensitivity C-Reactive Protein Levels: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Kianoush S; Bittencourt MS; Lotufo PA; Bensenor IM; Jones SR; DeFilippis AP; Toth PP; Otvos JD; Tibuakuu M; Hall ME; Harada PHN; Blaha MJ
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28838917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediagnostic Glycoprotein Acetyl Levels and Incident and Recurrent Flare Risk Accounting for Serum Urate Levels: A Population-Based, Prospective Study and Mendelian Randomization Analysis.
    Joshi AD; McCormick N; Yokose C; Yu B; Tin A; Terkeltaub R; Merriman TR; Eliassen AH; Curhan GC; Raffield LM; Choi HK
    Arthritis Rheumatol; 2023 Sep; 75(9):1648-1657. PubMed ID: 37043280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.